Ovarian Cancer Trial, By Invitation NCT07036952 Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, By Invitation

NCT07036952
By Invitation Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Polycystic Ovary Syndrome (PCOS) using a specific set of recognised diagnostic guidelines called the Rotterdam criteria
  • You are between 18 and 35 years old
  • Your PCOS diagnosis is new (recently diagnosed for the first time)

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have a history of diabetes (unless you also have a condition called metabolic syndrome — confirm with trial site)
  • You have any long-term (chronic) illness, such as liver disease, kidney disease, or heart disease
  • You have any current or ongoing infection or inflammatory condition
  • You have been taking Omega-3 supplements within the last three months
  • You have another condition that can look similar to PCOS, such as certain hormonal or gland-related disorders (confirm with trial site)
  • You have a known allergy to fish oil or Omega-3 supplements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Registry
ClinicalTrials.gov
Start date
22 April 2025
Est. completion
30 October 2025

Where this trial is recruiting

Bangladesh

Primary endpoints

Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov